Capricor Therapeutics’ cell therapy for Duchenne muscular dystrophy has come up short at the FDA, with the regulator rejecting the biotech’s application seeking regulatory approval for ...
This week, five federal policy makers introduced legislation that would extend CMS’ waiver for hospital-at-home reimbursement by five years.
Three representatives — Vern Buchanan ...
At ProviderTrust, one theme emerges repeatedly with our payer clients: messy, inaccurate, disconnected data. So, when our team received the results of a payer-focused survey conducted in ...
When I first came to the United States from Santiago, Chile at age 16, I brought with me a deep admiration for public health. My grandmother was a public health nurse, and from an early ...
Antibodies that bind to two targets are an established way of treating the blood cancer multiple myeloma. Aiming to top those medicines, AbbVie has secured rights to an early-clinical ...
AI is no panacea, but it can have a role in turning artisanal, trial-and-error drug development into a rapid, cost-effective, data-driven process.
The post AI Meets Gene Editing: the Path to ...
The growing prominence of health tech enlisting artificial intelligence has led to a lot of practical applications for automating a wide variety of administrative tasks, analyzing ...
Is your healthcare startup using AI to transform healthcare? MedCity INVEST Digital Health in Dallas, held in collaboration with Health Wildcatters at Pegasus Park on September 18, is ...
Watch the interview here
https://www.youtube.com/watch?v=7weUOEYVr0k
Listen to the episode here
Hypertension remains one of the country’s most prevalent yet most ...
GLP-1 receptor agonists like semaglutide and tirzepatide have redefined what’s possible in the treatment of obesity and metabolic syndrome. These medications have shown remarkable ...
In a healthcare system already stretched thin by rising costs, staff burnout, and fragmented post-acute care, the Centers for Medicare & Medicaid Services (CMS) is upping the ante.
...
Newborns have been underserved when it comes to medical products for malaria. The drugs and vaccines available to adults and older children are not approved for babies — those doses are ...